Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a late-stage pharmaceutical company with a broad ...

Two posters presented at the 2024 American Society of Hematology meeting reported real-world outcomes data for patients ...

A phase 3 trial confirms “the potent anti-leukemic effect” of consolidation with allogeneic transplant in older patients with acute myeloid leukemia, according to researchers.

Interesting trends were observed in the subgroup analyses of the phase 3 uproleselan study in relapsed or refractory acute ...

Venetoclax is under clinical development by AbbVie and currently in Phase II for Refractory Acute Myeloid Leukemia.

Xi'an "4+7" results announced, 8 more varieties added AbbVie's Phase III study of Venclexta + cytarabine as first-line treatment did not reach the primary endpoint 8 milestone clinical data in 2020Q1 ...

Martin Dreyling, MD, University Hospital LMU Munich, in Germany, discusses the final follow-up results of the TRIANGLE study ...

INR:3629. betting on the premier league Solving the mystery of tumor hijacking nerve cells has led scientists to discover the anti-cancer potential ...

INR:7553. freshnet farms private limited The new version of the medical insurance catalogue implements three PD-1 products, and the prices are expo ...

INR:6711. kerala football team vs meghalaya football team standings The price of cytarabine has increased by 120%, and t ...

INR:6567. how to request a bet on bet365 John Chin, former Celgene China General Manager, Appointed Chief Commercial Officer of Antengene Makoto Ya ...